LINX Reflux Management System Policy
Customize your policy alerts
Sign up for all summacare policy alerts
Know when summacare releases new policies or updates existing guidance.
Monitor payer policy activity
Coverage of laparoscopic implantation and removal of the LINX magnetic esophageal sphincter augmentation device for GERD and other indications. The procedure is considered experimental, investigational, and non-covered for commercial and Medicare members.
No material clinical or coverage changes in this revision.
Coverage Criteria
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.